Works matching IS 03125963 AND DT 2020 AND VI 59 AND IP 2

Results: 15

Authors' Reply to Yu et al.: "Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?".

Published in:

2020

By:

Concordet, Didier;
Gandia, Peggy;
Montastruc, Jean-Louis;
Bousquet-Mélou, Alain;
Lees, Peter;
Ferran, Aude A.;
Toutain, Pierre-Louis

Publication type:

Letter

Authors' Reply to Nicolas: "Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Published in:

2020

By:

Concordet, Didier;
Gandia, Peggy;
Montastruc, Jean-Louis;
Bousquet-Mélou, Alain;
Lees, Peter;
Ferran, Aude A.;
Toutain, Pierre-Louis

Publication type:

Letter

Comment on "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?".

Published in:

2020

By:

Yu, Yang;
Maliepaard, Marc

Publication type:

Letter

Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Published in:

2020

By:

Nicolas, Patrick

Publication type:

Letter

Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Published in:

2020

By:

Concordet, D.;
Gandia, P.;
Montastruc, J. L.;
Bousquet-Mélou, A.;
Lees, P.;
Ferran, A. A.;
Toutain, P. L.

Publication type:

Letter

Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Published in:

2020

By:

Krebs-Brown, Axel;
Munafo, Alain;
Gaikwad, Sumedh;
Urgatz, Bogumila;
Castello-Bridoux, Claire

Publication type:

Letter

Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences.

Published in:

2020

By:

Haahr, Hanne;
Heise, Tim

Publication type:

journal article

Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated Review.

Published in:

2020

By:

Havens, Joshua P.;
Podany, Anthony T.;
Scarsi, Kimberly K.;
Fletcher, Courtney V.

Publication type:

journal article

A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.

Published in:

2020

By:

Janssen, Julie M.;
Dorlo, T. P. C.;
Niewerth, D.;
Wilhelm, A. J.;
Zwaan, C. M.;
Beijnen, J. H.;
Attarbaschi, A.;
Baruchel, A.;
Fagioli, F.;
Klingebiel, T.;
De Moerloose, B.;
Palumbo, G.;
von Stackelberg, A.;
Kaspers, G. J. L.;
Huitema, A. D. R.

Publication type:

journal article

Drug Exposure to Establish Pharmacokinetic-Response Relationships in Oncology.

Published in:

2020

By:

Solans, Belén P.;
Garrido, María Jesús;
Trocóniz, Iñaki F.

Publication type:

journal article

Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup.

Published in:

2020

By:

Chelle, Pierre;
Yeung, Cindy H. T.;
Croteau, Stacy E.;
Lissick, Jennifer;
Balasa, Vinod;
Ashburner, Christina;
Park, Young Shil;
Bonanad, Santiago;
Megías-Vericat, Juan Eduardo;
Nagao, Azusa;
Wynn, Tung;
Corrales-Medina, Fernando;
Tran, Huyen;
Sharathkumar, Anjali;
Chitlur, Meera;
Sarmiento, Samuel;
Edginton, Andrea;
Iorio, Alfonso

Publication type:

journal article

Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects.

Published in:

2020

By:

Pérez-Ruixo, Carlos;
Pérez-Blanco, Jonás Samuel;
Chien, Caly;
Yu, Margaret;
Ouellet, Daniele;
Pérez-Ruixo, Juan-José;
Ackaert, Oliver

Publication type:

journal article

Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies.

Published in:

2020

By:

Ogasawara, Ken;
Newhall, Kathryn;
Maxwell, Stephen E.;
Dell'Aringa, Justine;
Komashko, Vitalina;
Kilavuz, Nurgul;
Delarue, Richard;
Czuczman, Myron;
Sternas, Lars;
Rose, Shelonitda;
Beach, C. L.;
Novick, Steven;
Zhou, Simon;
Palmisano, Maria;
Li, Yan

Publication type:

journal article

Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.

Published in:

2020

By:

Hartman, Stan J. F.;
Brüggemann, Roger J.;
Orriëns, Lynn;
Dia, Nada;
Schreuder, Michiel F.;
de Wildt, Saskia N.

Publication type:

journal article

Population Pharmacokinetics of Intravenous Salbutamol in Children with Refractory Status Asthmaticus.

Published in:

2020

By:

Vet, Nienke J.;
de Winter, Brenda C. M.;
Koninckx, Muriel;
Boeschoten, Shelley A.;
Boehmer, Annemie L. M.;
Verhallen, Jacintha T.;
Plötz, Frans B.;
Vaessen-Verberne, Anja A.;
van der Nagel, Bart C. H.;
Knibbe, Catherijne A. J.;
Buysse, Corinne M. P.;
de Wildt, Saskia N.;
Koch, Birgit C. P.;
de Hoog, Matthijs

Publication type:

journal article

Works matching IS 03125963 AND DT 2020 AND VI 59 AND IP 2

Authors' Reply to Yu et al.: "Levothyrox<sup>®</sup> New and Old Formulations: Are They Switchable for Millions of Patients?".

Authors' Reply to Nicolas: "Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Comment on "Levothyrox<sup>®</sup> New and Old Formulations: Are they Switchable for Millions of Patients?".

Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences.

Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated Review.

A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.

Drug Exposure to Establish Pharmacokinetic-Response Relationships in Oncology.

Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate<sup>®</sup>): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup.

Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects.

Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies.

Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.

Population Pharmacokinetics of Intravenous Salbutamol in Children with Refractory Status Asthmaticus.